Atlas Trials

The Safety and Efficacy of Umbilical Cord Blood Mononuclear Cells in Patients With Secondary Poor Graft Function After Hematopoietic Stem Cell Transplantation

Clinical trial NCT06792682 · RECRUITING

Trial details

NCT number
NCT06792682
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Poor Graft Function
Start date
2025-02-14
Primary completion
2027-12-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.